The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft
ContributorsBeauverd, Yan; Morin, Sarah; Stephan, Caroline; De Ramon Ortiz, Carmen Julia; Fabra Urdiola, Marta; Giannotti, Federica; Mahne, Elif; Mamez, Anne-Claire; Mappoura, Maria; Simonetta, Federico; Tran, Thien-An; Ayer, Christian; Noetzlin, Sarah Audrey; Verdon, Isaline; Masouridi Levrat, Stavroula; Chalandon, Yves
Published inBone marrow transplantation, vol. 56, no. 9, p. 2284-2286
Publication date2021-09
First online date2021-05-18
Keywords
- Cytogenetic Analysis
- Graft vs Host Disease
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myeloid, Acute / genetics
- Leukemia, Myeloid, Acute / therapy
- Prognosis
- Retrospective Studies
- Risk Factors
- T-Lymphocytes
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
BEAUVERD, Yan et al. The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft. In: Bone marrow transplantation, 2021, vol. 56, n° 9, p. 2284–2286. doi: 10.1038/s41409-021-01334-6
Main files (1)
Article (Published version)
Identifiers
- PID : unige:160536
- DOI : 10.1038/s41409-021-01334-6
- PMID : 34007052
Journal ISSN0268-3369
